Back to School: How biopharma can reboot drug development. Access exclusive analysis here

User fees a convenient source of funds

WASHINGTON - The Clinton administration has asked Congress to cut funding for the FDA by about 8 percent in the 1998 fiscal year beginning next October, but hopes to provide the agency with slightly more funds than it received in 1997 through the imposition of new user fees.

The proposal reflects the administration's support for the role FDA plays in supporting high-profile political causes. The budget documents highlight the administration's request for large increases in funding for anti-tobacco activities at the agency - but biotech industry officials and public

Read the full 884 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE